#MedNews - Intravitreal #brolucizumab appears to be efficacious for achieving fluid resolution and reducing macular thickness in chronic central serous #chorioretinopathy with persistent fluid.
Full story 👉 buff.ly/32omyC5
#EyeSky
0
0
0
0